U.S. court upholds patent on Forest’s Lexapro (Reuters via Yahoo! Asia News)
U.S. court upholds patent on Forest’s Lexapro (Reuters via Yahoo! Asia News)
NEW YORK, Sept 5 (Reuters) – A federal appeals court on Wednesday upheld a lower court ruling that the patent is valid on Forest Laboratories’ blockbuster depression drug Lexapro, thereby blocking sales of generic forms of the drug made by Teva Pharmaceuticals Ltd and Cipla Ltd .